Home
Science & Technology
Publications

Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
222 results found
Oct 7, 2020
Publication
Novavax led
Vaccine
Seasonal influenza
Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance
Bruce-Staskal, Pamela J., Woods, Robert M., Borisov, Oleg V. , et al.
View
Oct 1, 2020
Presentation
Seasonal influenza
NanoFlu™ Vaccine Update: Phase 3 ResultsVivek Shinde, MD, MPH, VP Clinical Development October 1st, 2020
Shinde, Vivek
View/Download
Oct 1, 2020
Presentation
RSV
Phase 3 and Beyond: Maternal RSV & Older Adult Influence Vaccine Program

World Vaccine Congress Washington 2020

Glenn, Gregory
View/Download
Sep 28, 2020
Presentation
COVID-19
Recombinant nanoparticle COVID-19 vaccine: Platform technology for EID (Emerging Infectious Diseases)

World Vaccine Congress Washington 2020

Glenn, Gregory
View/Download
Aug 4, 2020
Presentation
COVID-19
NVX-CoV2373 COVID-19 Vaccine Candidate Phase 1/2, Part 1, Clinical Trial Results
View/Download
Jul 30, 2020
Publication
Novavax led
The New England Journal of Medicine
RSV
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
Madhi, Shabir A., Polack, Fernando P. , Piedra, Pedro A., et al.
View
Jul 21, 2020
Presentation
COVID-19
Progress with the Full Length Recombinant Spike Protein Nanoparticle Vaccine

2nd ISV COVID-19 Vaccines Virtual Congress

View/Download
Jun 27, 2020
Publication
Novavax led
The Journal of Infectious Diseases
RSV
Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection
Tseng, Hung Fu, Sy, Lina S., Ackerson, Bradley, et al.
View
Jun 23, 2020
Presentation
RSV
Learnings from a Phase 3 RSV Clinical Trial

New York Academy of Sciences: Innovations in Maternal, Neonatal, and Early Infancy Vaccines

Glenn, Gregory
View/Download
Jun 17, 2020
Publication
Novavax included/third party
Health Security
COVID-19, Matrix-M® adjuvant
Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks
Billington J, Deschamps I, Erck SC, et al.
View